CAW
RDY icon

Cornerstone Advisors (Washington)’s Dr. Reddy's Laboratories RDY Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$173K Sell
12,415
-45
-0.4% -$536 0.02% 121
2020
Q2 		$132K Buy
12,460
+2,980
+31% +$30.3K 0.01% 135
2020
Q1 		$76K Buy
9,480
+3,345
+55% +$27.9K 0.01% 169
2019
Q4 		$50K Buy
6,135
+890
+17% +$7.03K 0.01% 234
2019
Q3 		$40K Buy
5,245
+940
+22% +$6.99K 0.01% 250
2019
Q2 		$32K Sell
4,305
-440
-9% -$3.46K ﹤0.01% 527
2019
Q1 		$38K Buy
4,745
+2,290
+93% +$17.4K ﹤0.01% 450
2018
Q4 		$19K Buy
2,455
+565
+30% +$3.97K ﹤0.01% 521
2018
Q3 		$13K Buy
1,890
+325
+21% +$2.17K 0.01% 597
2018
Q2 		$10K Sell
1,565
-8,085
-84% -$51K 0.01% 614
2018
Q1 		$63K Buy
9,650
+215
+2% +$1.51K 0.04% 255
2017
Q4 		$71K Buy
9,435
+1,010
+12% +$7.27K 0.05% 234
2017
Q3 		$60K Sell
8,425
-940
-10% -$6.76K 0.04% 249
2017
Q2 		$79K Buy
9,365
+9,075
+3,129% +$73.8K 0.04% 208
2017
Q1 		$2K Sell
290
-4,255
-94% -$36.7K ﹤0.01% 810
2016
Q4 		$41K Buy
4,545
+2,215
+95% +$20.6K 0.03% 299
2016
Q3 		$22K Buy
+2,330
New +$22.2K 0.02% 470
2016
Q2 		– Sell
-125
Closed -$1K – 881
2016
Q1 		$1K Buy
125
+40
+47% +$358 ﹤0.01% 827
2015
Q4 		$1K Sell
85
-165
-66% -$1.81K ﹤0.01% 845
2015
Q3 		$3K Hold
250
– – ﹤0.01% 660
2015
Q2 		$3K Buy
250
+110
+79% +$1.22K ﹤0.01% 527
2015
Q1 		$2K Buy
140
+55
+65% +$583 ﹤0.01% 642
2014
Q4 		$1K Buy
+85
New +$895 ﹤0.01% 720

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AG
Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Cornerstone Advisors (Washington)'s RDY Position: Q3 2020 in Review

Cornerstone Advisors (Washington) reduced its Dr. Reddy's Laboratories (RDY) stake by 0.36% in Q3 2020, selling an estimated $536 and leaving 12,415 shares worth $173K. The position accounts for 0.02% of the portfolio, ranked #121.

Cornerstone Advisors (Washington) first reported a position in RDY in Q4 2014 and has held it in 23 quarters since. 186 funds tracked by Wall St. Rank hold RDY as of Q3 2020.

  • Cornerstone Advisors (Washington) held 12,415 shares of Dr. Reddy's Laboratories worth $173K as of Q3 2020.
  • Cornerstone Advisors (Washington) sold 45 Dr. Reddy's Laboratories shares in Q3 2020, an estimated $536.
  • Dr. Reddy's Laboratories made up 0.02% of Cornerstone Advisors (Washington)'s portfolio in Q3 2020, its #121 holding.
  • Cornerstone Advisors (Washington) first reported a position in Dr. Reddy's Laboratories in Q4 2014 and has held it in 23 quarters since.
  • 186 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2020.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2020, filed 20 Oct 2020.